Medication info
Pharma Empagliflozin 10 mg (Empagliflozin)

Pharma Empagliflozin 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
Light yellow, double convex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102825 · Approved 2021.03.31 · Insurance code 653007120

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If additional glycemic control is needed and 10 mg of this medicine is well tolerated, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. Do not take double the dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medicine should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to less than 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered. As clinical experience in older adults aged 85 years and older is limited, initiation of this medicine is not recommended (see Precautions for Use, 4. General Precautions).

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in adults with type 2 diabetes in conjunction with diet and exercise. It can be administered alone, and if blood sugar control is inadequate with monotherapy, it can be used in combination with metformin. Additionally, this medication can be added when blood sugar control is insufficient with metformin or other diabetes medications. Special caution is required for patients with type 2 diabetes and cardiovascular disease regarding the occurrence of cardiovascular events. This medication improves blood sugar control and aids in diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If additional glycemic control is needed and 10 mg of this medicine is well tolerated, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. Do not take double the dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medicine should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to less than 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered. As clinical experience in older adults aged 85 years and older is limited, initiation of this medicine is not recommended (see Precautions for Use, 4. General Precautions).

Precautions

This medication should not be used in patients with known allergies to the active ingredient or any other component. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. It is not indicated for patients with significantly impaired kidney function, specifically those with a glomerular filtration rate (GFR) below 30 mL/min/1.73m2, patients with end-stage renal disease, or those undergoing dialysis. Additionally, this medication contains lactose, and it should not be administered to patients with genetic conditions such as lactase deficiency, galactose intolerance, or glucose-galactose malabsorption. Caution is advised when using this medication in patients with impaired kidney function, and treatment should be avoided if the GFR is below 60 mL/min/1.73m2, and it should be discontinued if it falls below 45 mL/min/1.73m2. In patients with end-stage renal disease or those undergoing dialysis, the effectiveness of this medication is not expected, hence it is not used. In patients with mild to moderate heart failure, caution is advised, and it is not recommended for patients with severe heart failure. When used in conjunction with insulin or sulfonylureas, there is a risk of hypoglycemia, and dosage adjustment for these medications may be required. During treatment with this medication, adverse reactions such as hypoglycemia, genital infections, urinary tract infections, increased urination, and fluid volume depletion may occur, necessitating attention. Especially, serious metabolic abnormalities like ketoacidosis can occur rarely; if symptoms like nausea, vomiting, abdominal pain, and difficulty breathing occur, immediate consultation with a healthcare professional is advised. Older adults, particularly those over 75, are at greater risk of fluid volume loss, and caution should be taken to avoid dehydration or hypotension; for those over 85, the use of this medication is not recommended. Since this medication affects blood sugar levels, it may influence certain testing methods during blood glucose monitoring, so it needs to be monitored per medical advice. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding mothers should discontinue nursing while using this medication. The safety and efficacy in children under 18 have not been established, so it is not used. In cases of overdose, no specific toxic symptoms have been reported, but appropriate treatment should be sought based on clinical status. This medication should be kept out of the reach of children, and it is advisable not to transfer it to another container. Drug interactions may increase the risk of dehydration or hypotension when used with diuretics, and caution is warranted when used with insulin or insulin secretagogues due to the risk of hypoglycemia. Caution is needed when driving or operating machinery due to the risk of hypoglycemia. Diabetic patients should pay attention to routine foot care and should be cautious regarding the risk of limb amputation. Serious infections such as perineal necrosis can occur rarely, so immediate medical attention should be sought for pain, swelling, fever, or other symptoms around the genital area.

Side effects

  • Hypoglycemia
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • ketoacidosis
  • itching
  • rash
  • urticaria
Show 180 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • unstable angina
  • diarrhea
  • dyspepsia
  • abdominal pain
  • gastritis
  • nasopharyngitis
  • herpes zoster
  • dizziness
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral artery obstructive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • flatulence
  • gastric polyp
  • gingival swelling
  • hematochezia
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea capitis
  • dental abscess
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • scrotal pain
  • sexual dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will safely maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Light yellow, double convex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.